Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292320032> ?p ?o ?g. }
- W4292320032 endingPage "179" @default.
- W4292320032 startingPage "166" @default.
- W4292320032 abstract "Diabetes mellitus can result in severe complications, such as neurodegenerative diseases including cognitive impairment and dementia. The glucagon-like peptide-1 (GLP-1) receptor agonist, liraglutide, is a novel antidiabetic drug with neuroprotective effects against neurodegenerative diseases. In this study, we explored the protective effect of liraglutide on SH-SY5Y cells exposed to methylglyoxal (MG), a byproduct of glucose metabolism that plays a key role in the development of diabetic encephalopathy. We found that liraglutide reduced the MG-induced oxidative stress, increased the activity of superoxide dismutase (SOD) and expression levels of P22phox, Gp91phox, and Xdh genes, and reduced reactive oxygen species (ROS) content. Metabolomics analysis based on 1H nuclear magnetic resonance showed that liraglutide induced alterations in metabolites involved in energy metabolism，including promotion of gluconeogenesis. Moreover, we found that liraglutide promoted oxidative phosphorylation and inhibited glycolysis in SH-SY5Y cells. This study revealed that liraglutide improved diabetes-related neuropathy damage by reducing the level of oxidative stress and maintaining the balance of energy metabolism, thus offering new insights into the potential mechanism of liraglutide in neuronal protection." @default.
- W4292320032 created "2022-08-19" @default.
- W4292320032 creator A5002551693 @default.
- W4292320032 creator A5022065654 @default.
- W4292320032 creator A5023736025 @default.
- W4292320032 creator A5029808384 @default.
- W4292320032 creator A5035644244 @default.
- W4292320032 creator A5039347763 @default.
- W4292320032 creator A5040290706 @default.
- W4292320032 creator A5048145081 @default.
- W4292320032 creator A5061550410 @default.
- W4292320032 creator A5061778776 @default.
- W4292320032 date "2022-09-01" @default.
- W4292320032 modified "2023-10-16" @default.
- W4292320032 title "Liraglutide reduces oxidative stress and improves energy metabolism in methylglyoxal-induced SH-SY5Y cells" @default.
- W4292320032 cites W1552936749 @default.
- W4292320032 cites W1882356554 @default.
- W4292320032 cites W1918985013 @default.
- W4292320032 cites W1967197502 @default.
- W4292320032 cites W1968362444 @default.
- W4292320032 cites W1975066065 @default.
- W4292320032 cites W1975296792 @default.
- W4292320032 cites W1980451348 @default.
- W4292320032 cites W2004356308 @default.
- W4292320032 cites W2022267544 @default.
- W4292320032 cites W2025639892 @default.
- W4292320032 cites W2030809658 @default.
- W4292320032 cites W2038335142 @default.
- W4292320032 cites W2038350512 @default.
- W4292320032 cites W2042306938 @default.
- W4292320032 cites W2060170946 @default.
- W4292320032 cites W2065789765 @default.
- W4292320032 cites W2070337941 @default.
- W4292320032 cites W2071214407 @default.
- W4292320032 cites W2072903475 @default.
- W4292320032 cites W2080900759 @default.
- W4292320032 cites W2085128107 @default.
- W4292320032 cites W2088190876 @default.
- W4292320032 cites W2093339420 @default.
- W4292320032 cites W2098685543 @default.
- W4292320032 cites W2104665168 @default.
- W4292320032 cites W2106573766 @default.
- W4292320032 cites W2108791332 @default.
- W4292320032 cites W2109061188 @default.
- W4292320032 cites W2115467405 @default.
- W4292320032 cites W2211963426 @default.
- W4292320032 cites W2336925368 @default.
- W4292320032 cites W2344081812 @default.
- W4292320032 cites W2344913091 @default.
- W4292320032 cites W2347041376 @default.
- W4292320032 cites W2423710865 @default.
- W4292320032 cites W2440900827 @default.
- W4292320032 cites W2465891165 @default.
- W4292320032 cites W2519152280 @default.
- W4292320032 cites W2521868986 @default.
- W4292320032 cites W2527740737 @default.
- W4292320032 cites W2569635760 @default.
- W4292320032 cites W2570987822 @default.
- W4292320032 cites W2735844318 @default.
- W4292320032 cites W2766388141 @default.
- W4292320032 cites W2789253060 @default.
- W4292320032 cites W2791422493 @default.
- W4292320032 cites W2792544397 @default.
- W4292320032 cites W2792585107 @default.
- W4292320032 cites W2805622227 @default.
- W4292320032 cites W2887280072 @default.
- W4292320032 cites W2899097516 @default.
- W4292320032 cites W2899221139 @default.
- W4292320032 cites W2906515429 @default.
- W4292320032 cites W2911493122 @default.
- W4292320032 cites W2919702623 @default.
- W4292320032 cites W2920206882 @default.
- W4292320032 cites W2921570078 @default.
- W4292320032 cites W2949165337 @default.
- W4292320032 cites W2966966909 @default.
- W4292320032 cites W2985831364 @default.
- W4292320032 cites W2997549649 @default.
- W4292320032 cites W3128970005 @default.
- W4292320032 doi "https://doi.org/10.1016/j.neuro.2022.08.007" @default.
- W4292320032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35985417" @default.
- W4292320032 hasPublicationYear "2022" @default.
- W4292320032 type Work @default.
- W4292320032 citedByCount "3" @default.
- W4292320032 countsByYear W42923200322023 @default.
- W4292320032 crossrefType "journal-article" @default.
- W4292320032 hasAuthorship W4292320032A5002551693 @default.
- W4292320032 hasAuthorship W4292320032A5022065654 @default.
- W4292320032 hasAuthorship W4292320032A5023736025 @default.
- W4292320032 hasAuthorship W4292320032A5029808384 @default.
- W4292320032 hasAuthorship W4292320032A5035644244 @default.
- W4292320032 hasAuthorship W4292320032A5039347763 @default.
- W4292320032 hasAuthorship W4292320032A5040290706 @default.
- W4292320032 hasAuthorship W4292320032A5048145081 @default.
- W4292320032 hasAuthorship W4292320032A5061550410 @default.
- W4292320032 hasAuthorship W4292320032A5061778776 @default.
- W4292320032 hasConcept C126322002 @default.
- W4292320032 hasConcept C134018914 @default.
- W4292320032 hasConcept C181199279 @default.